Scientists from The Scripps Research Institute, Scripps Health, and collaborating cancer physicians have successfully demonstrated the effectiveness of an advanced blood test for detecting and analyzing circulating tumor cells (CTCs)—breakaway cells from patients’ solid tumors—from cancer patients. The findings, reported …
read full article